Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Oral Cavity Squamous Cell Carcinoma and Readmission: Rates, Causes, and Risk Factors.

NCT06259838 is registered in ClinicalTrials.gov with Abdulsalam Alqutub as lead sponsor.

NCT NCT06259838
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06259838 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Oral Cavity Squamous Cell Carcinoma and Readmission: Rates, Causes, and Risk Factors.
Lead sponsor
Abdulsalam Alqutub
Phase
Observational
Overall status
Completed
Start date
January 1, 2023
Completion date
February 7, 2024
Enrollment
93 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

oral cavity squamous cell carcinoma; readmission